The current valuation score of Armata Pharmaceuticals Inc is 8.40, ranking 126 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.60, which is -100.00% below the recent high of 0.00 and -35594.89% above the recent low of -215.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.